Aims-To investigate the reaction of antibodies OV 632 and MOC 31 in paraffin wax sections as opposed to frozen sections and cytological preparations; to evaluate their usefulness in the differential diagnosis of malignant mesothelioma and secondary adenocarcinoma ofthe pleura; and to assess the efficacy of microwave pretreatment of sections in unmasking their associated epitopes. Methods-Immunohistochemistry, using a standard avidin-biotin technique, with microwave pretreatment and trypsinisation in a certain proportion of cases. The material comprised 43 mesotheliomas, 44 adenocarcinomas and five reactive pleuras. Results-Epithelial mesotheliomas and the hyperplastic mesothelial cells reacted strongly with OV 632, the reaction with sarcomatoid and desmoplastic tumours was weak, and the reaction with adenocarcinomas was variable. An unequivocal but sometimes patchy positive reaction was obtained with MOC 31 in all but one of the adenocarcinomas; all but one of the mesotheliomas and all the reactive pleuras were negative. Review ofthe two apparently anomalous cases revealed that the original diagnoses had probably been incorrect. Reactions to both antibodies were abolished by microwave pretreatment, and also by prior trypsinisation in the case of OV 632. Conclusions-OV 632 is unsuitable for routine clinical use in paraffin wax embedded material. MOC 31, however, would be a useful addition to a panel ofantibodies in the differential diagnosis of mesothelioma and adenocarcinoma in large biopsy and resection specimens and necropsy material. Its value in small biopsy specimens remains to be assessed. Microwave pretreatment does not enhance the reactions with either antibody. (J7 Clin Pathol 1995;48:626-630) Keywords: OV 632, MOC 31, adenocarcinoma, mesothelioma.
wax sections as opposed to frozen sections and cytological preparations; to evaluate their usefulness in the differential diagnosis of malignant mesothelioma and secondary adenocarcinoma ofthe pleura; and to assess the efficacy of microwave pretreatment of sections in unmasking their associated epitopes. Methods-Immunohistochemistry, using a standard avidin-biotin technique, with microwave pretreatment and trypsinisation in a certain proportion of cases. The material comprised 43 mesotheliomas, 44 adenocarcinomas and five reactive pleuras. Results-Epithelial mesotheliomas and the hyperplastic mesothelial cells reacted strongly with OV 632, the reaction with sarcomatoid and desmoplastic tumours was weak, and the reaction with adenocarcinomas was variable. An unequivocal but sometimes patchy positive reaction was obtained with MOC 31 in all but one of the adenocarcinomas; all but one of the mesotheliomas and all the reactive pleuras were negative. Review ofthe two apparently anomalous cases revealed that the original diagnoses had probably been incorrect. Reactions to both antibodies were abolished by microwave pretreatment, and also by prior trypsinisation in the case of OV 632. Conclusions-OV 632 is unsuitable for routine clinical use in paraffin wax embedded material. MOC 31, however, would be a useful addition to a panel ofantibodies in the differential diagnosis of mesothelioma and adenocarcinoma in large biopsy and resection specimens and necropsy material. Its value in small biopsy specimens remains to be assessed. Microwave pretreatment does not enhance the reactions with either antibody. The differentiation between adenocarcinomatous infiltration of the pleura and mesothelioma is often difficult, particularly in small biopsy specimens. Conventional stains for epithelial and connective tissue mucosubstances can be helpful, but lack specificity,'2 and although long microvilli are almost pathognomonic of mesothelioma, material for electron microscopy is frequently unavailable. For some years now, immunocytochemical methods have been employed, using a variety of antibodies.`Unfortunately, no single antibody is wholly specific: vimentin and keratins are expressed by both carcinomas and mesotheliomas; LEU Ml is not expressed by mesothelioma, but a significant proportion of adenocarcinomas are also negative; and although mesothelioma is usually negative for carcinoembryonic antigen (CEA), non-specific cross reactions frequently occur. immunohistochemically for OV 632 by a standard avidin-biotin complex technique, using a mouse anti-OV 632 antibody at a dilution of 1 in 10, as recommended by the manufacturers (Euro-Path Ltd, Bude, Cornwall, UK). The second section was placed in a Toshiba ER-7700E domestic microwave oven (2450 mHz: 240 V: 5-6A) and treated at the "full power" setting for 10 minutes before staining; the third section was pretreated with trypsin by a standard method. In three of the mesothelioma cases additional sections were cut and microwave treatment was continued for 20 and 30 minutes. The reactions were controlled by a series of blank sections, in which the antibody was replaced by phosphate buffered saline.
MOC 31
In this part of the study a total of 87 cases was investigated. These comprised 43 mesotheliomas, of which 23 were resection specimens or large open biopsy specimens; the remainder were necropsy specimens. Twenty eight were of the epithelial subtype, eight were mixed, four were sarcomatoid, and three desmoplastic. appeared as a thin line of reaction product coating the internal surface of the alveoli. The reaction was abolished by microwave preThere was no consistent reaction in the lung parenchyma adjacent to the adenocarcinomas, but the overlying normal pleura gave a positive reaction which was abolished by both microwave pretreatment and trypsinisation. In all of the sections examined microwave pretreatment induced a positive cytoplasmic reaction in alveolar and non-alveolar macrophages.
All but one of the adenocarcinomas gave a strong, but sometimes rather patchy, positive reaction to this antibody. In each case the reaction was either confined to the cell membrane, or was associated with minimal staining of the cytoplasm (fig 3) . The reaction was quenched by microwave pretreatment.
On review of the negative tumour, it was found that there had been widespread involvement of the pleura at necropsy. The diagnosis of adenocarcinoma had been made on the basis of a scanty and granular positive histochemical reaction for epithelial mucosubstances, using periodic acid-Schiff with and without diastase, and alcian blue with and without hyaluronidase. Morphologically, with haematoxylin and eosin alone, the distinction between adenocarcinoma and mesothelioma was not possible and the exact nature of this tumour remains uncertain.
With a single exception, all of the mesotheliomas were negative, although in some cases there were small, probably artefactual foci of positivity, involving isolated cells or small clusters. There was no unmasking of the epitope by microwave pretreatment or trypsinisation. The positive tumour showed the same heavy membrane reaction seen in the adenocarcinomas. Pleural infiltration characteristic of mesothelioma had been found at necropsy, but there had been no history of asbestos exposure and no asbestos was detected in the lung parenchyma by either light or electron microscopy. The patient had, however, been treated for Hodgkin's lymphoma at six years of age. A careful review of the sections treatment and by trypsinisation. Normal pleura was negative. 
of affairs which may lead to diagnostic errors.-7 OV 632, on the other hand, appeared to be unique in that it gives a positive reaction with mesothelioma, albeit in cytological preparations. If the blocking of the reaction by routine fixation and processing could be overcome, it would be a valuable addition to the battery of antibodies currently used in this context.-7 It has recently been shown that microwave irradiation often enhances immunohistochemical reactions, and may "retrieve" epitopes that have previously only been demonstrable in frozen sections.'415 Accordingly, we investigated the effect of microwave pretreatment on the reactivity of OV 632 with paraffin wax embedded and formalin fixed material, in the hope that the epitope would be unmasked.
The results of this part of the study were unexpected in that the antibody reacted strongly with untreated sections of most of the epithelial mesotheliomas, and rather less strongly with the sarcomatoid and desmoplastic mesotheliomas. Untreated sections of reactive pleura were also strongly positive and the reaction with adenocarcinomas was variable. Both the microwaved and trypsinised sections were negative. These results are at variance with those obtained by other investigators;
we have no explanation except that they may be due to the use of a different batch ofantibody. It is certain, however, that although the antibody we used reacted in a way that merits further study, OV 632 cannot be relied upon to differentiate between adenocarcinoma and mesothelioma in paraffin wax sections.
MOC 31 is the prototype reagent of cluster 2 as defined at the Second International Workshop on Lung Cancer Antigens." 16 It recognises a 40 kDa transmembrane glycoprotein ofuncertain function, located on the membrane of certain epithelial cells, including those of adenocarcinoma. To our knowledge, MOC 31 has only been evaluated in two studies, both of which were cytological. In the first,9 MOC 31 positivity was seen in cells from effusions in seven of 10 adenocarcinomas of lung, and in 11 of 20 specimens from patients with effusions due to adenocarcinomas from other sites: only one of seven effusions arising as a result of secondary carcinoma of the breast contained positive cells. Fluid samples from 24 mesotheliomas were examined, and only two were positive. These data were re-presented by the same group in a further paper two years later.'0
In the second investigation," in which effusions from 98 patients were studied, positive cells were seen in all but one of 59 cases of secondary carcinoma. The primary sites included lung, breast and thyroid, and the gastrointestinal and genito-urinary tracts. The single exception was a case ofsecondary squamous carcinoma. The cells in the fluid samples from 29 patients with reactive effusions, and from five with mesothelioma, were negative. The authors concluded that MOC 31 is a highly selective and reliable discriminator between epithelial and mesothelial cells, and is certainly more specific and sensitive than the other antibodies used in the study, which included CEA, epithelial membrane antigen, cytokeratins of differing molecular weights, and vimentin.
Our experience with this antibody indicates that it is equally effective in formalin fixed, paraffin wax embedded material, and that in discriminating between adenocarcinomatous infiltration of the pleura and malignant mesothelioma, it compares favourably in its performance with other antibodies. Leu Ml, for instance, reacts with about 75% of adenocarcinomas and with up to 6% of mesotheliomas35; B72f3 has recently been reported to react with 93 of 103 adenocarcinomas, whereas 34 mesotheliomas were negative.5 In this same study CEA reacted with 100 of the adenocarcinomas and with only three of the mesotheliomas: less specific results were obtained with secretory component and CA 125, while vimentin and thrombomodulin were unhelpful.
The lack of specificity of the various antibodies that have been advocated from time to time to assist the differential diagnosis of these two tumours and the absence of a positive antibody for mesothelioma have led to the use of panels of antibodies. Currently, the most useful panel would appear to consist of CEA, Leu Ml and B72-3,5 but even then some care must be taken in the selection of reagents. There are, for instance, numerous antibodies to CEA which recognise at least five epitope clusters, each with different sensitivities and specificities,6 and some published data suggest that B72-3 may react with 21% of mesotheliomas.5 Moreover, the results of any investigation are, as Weiss 
